Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Catheter ablation Stories

2012-01-17 07:01:00

MARLBOROUGH, Mass., Jan. 17, 2012 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that a new study in the Journal of Cardiovascular Electrophysiology demonstrates the high acute and chronic success rates achievable with a single AF ablation procedure using HeartLight EAS. The study was conducted by Boris Schmidt, MD, and colleagues at Cardioangiologisches Centrum Bethanien,...

2012-01-06 07:01:00

MARLBOROUGH, Mass., Jan. 6, 2012 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced that it is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Tuesday, January 10, 2012 at 10:30 a.m. PT. The presentation by Stephen Sagon, CardioFocus President and CEO, will provide an overview of the company's business, clinical and commercial successes...

2011-11-08 07:00:00

MARLBOROUGH, Mass., Nov. 8, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that its HeartLight EAS will be discussed as a state-of-the-art technology and featured in a patient case presentation at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, November 7-11, San Francisco, CA. TCT is...

2011-10-12 11:16:00

MARLBOROUGH, Mass., Oct. 12, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that its HeartLight EAS was used to achieve successful acute PV isolation and restore sinus rhythm in a persistent AF patient during a live case at the Venice Arrhythmias 2011 conference, October 9-12 in Venice, Italy. Additionally, research presented during the scientific sessions further supports...

2011-09-28 07:15:00

DALLAS, Sept. 28, 2011 /PRNewswire/ -- September 2011 is the fifth annual Atrial Fibrillation Awareness Month. Raising afib awareness is intensely personal for StopAfib.org founder Mellanie True Hills and led her to create the first Atrial Fibrillation Awareness Month in 2007. Working with other organizations, Hills helped urge the U.S. Senate to officially designate National Atrial Fibrillation Awareness Month in September 2009. For Hills, a highlight of Afib Month 2011 was the privilege...

2011-09-13 11:20:36

Majority of cryoballoon ablation patients show no signs of a-fib year after procedure Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans. However, new research shows that 70 percent of patients with the disorder who were treated with cryoballoon ablation, the freezing technique, are free of any...

2011-09-12 16:11:00

Majority of Cryoballoon Ablation Patients Show No Signs of A-fib Year After Procedure CHICAGO, Sept. 12, 2011 /PRNewswire-USNewswire/ -- Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans. However, new research shows that 70 percent of patients with the disorder who were treated with cryoballoon...

2011-08-31 23:31:06

Study shows noninvasive, fast way to map heart's electrical activity in one heartbeat Just one second, one heartbeat. That's what is needed for a new, noninvasive functional imaging technology to record data for locating the source in the heart of a dangerous cardiac arrhythmia called ventricular tachycardia (VT). VT is an abnormal, fast beating of the heart, which, if ignored, can lead to ventricular fibrillation, which causes some 400,000 cases of sudden death yearly in the United...

2011-08-30 11:42:43

Many patients are looking for a drug-free lifestyle Results presented today from the Atrial Fibrillation Ablation Pilot Study show that almost 40% of patients undergoing a catheter ablation for atrial fibrillation have no underlying disease associated with the arrhythmia, and precipitating factors are rare. The survey, which is a pilot survey from the ESC's EurObservational registry program, also confirmed that symptoms are present in 86% of patients but vary considerably; symptoms include...

2011-08-22 06:01:00

MARLBOROUGH, Mass., Aug. 22, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that the HeartLight EAS is now available in the United Kingdom. The first AF patients were treated at The Heart Hospital in London on Wednesday, August 17, with additional cases to take place throughout the month. The procedures were performed by Drs. Edward Rowland and Oliver Segal, consultant...